Literature DB >> 1498270

Enantioselective versus non-enantioselective assays in comparative bioavailability studies with racemic drugs.

W D Hooper, R G Dickinson, J Gal.   

Abstract

Mesh:

Year:  1992        PMID: 1498270     DOI: 10.1002/bdd.2510130511

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


× No keyword cloud information.
  2 in total

Review 1.  Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods.

Authors:  R Mehvar; F Jamali
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

2.  Which bioequivalence study for a racemic drug? Application to milnacipran.

Authors:  D Deprez; D Chassard; P Baille; A Mignot; H L Ung; C Puozzo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.